Skip to main content

Social Capital Suvretta Holdings Corp. III Class A ordinary shares (DNAC)

About The Company

DNAC Stock Market Logo

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient’s own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient’s own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.

IPO Year Sector Industry
2021 N/A N/A

Social Capital Suvretta Holdings Corp. III (DNAC) Latest News

Company Contact & Address (DNAC)

Corporate Headquarters Phone Website
North Carolina,
United States
+1 336 999-7029 Official DNAC Website

DNAC Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector N/A P/E Ratio Not Available
Industry N/A Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ DNAC

Jobs & Employment at Social Capital Suvretta Holdings Corp. …

LinkedIn Company Page
Official Career & Employment Page See LinkedIn page for the careers & employment details.

Related & Similar Stock Symbols

MBWM Stock Market Price & News


Mercantile Bank Corporation Common Stock

EGHT Stock Market Price & News


8×8 Inc Common Stock

RVLV Stock Market Price & News


Revolve Group Inc. Class A Common Stock